| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/EJI.200940157 |
| P8608 | Fatcat ID | release_nkxmdym3ffftjcmawrlft4jndy |
| P698 | PubMed publication ID | 20397212 |
| P5875 | ResearchGate publication ID | 43161698 |
| P50 | author | Yoichiro Iwakura | Q56564114 |
| P2093 | author name string | Kenji Chamoto | |
| Takashi Nishimura | |||
| Hiroyoshi Nishikawa | |||
| Takayuki Ohkuri | |||
| Hidemitsu Kitamura | |||
| Daiko Wakita | |||
| Kentaro Sumida | |||
| P2860 | cites work | The biological functions of T helper 17 cell effector cytokines in inflammation | Q24614431 |
| A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses | Q24630221 | ||
| T helper 17 cells promote cytotoxic T cell activation in tumor immunity | Q24646584 | ||
| Tumor-specific Th17-polarized cells eradicate large established melanoma | Q24648032 | ||
| Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis | Q60241749 | ||
| CCR6 and NK1.1 distinguish between IL-17A and IFN-γ-producing γδ effector T cells | Q60709864 | ||
| Expression of IL-17 mRNA in ovarian cancer | Q74008184 | ||
| Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells | Q82930126 | ||
| Cancer-related inflammation | Q27860907 | ||
| Regulation of cutaneous malignancy by gammadelta T cells | Q28188439 | ||
| IL-23 promotes tumour incidence and growth | Q28239522 | ||
| Interferons, immunity and cancer immunoediting | Q28270336 | ||
| TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells | Q28296956 | ||
| Antagonistic roles of CD4+ and CD8+ T-cells in 7,12-dimethylbenz(a)anthracene cutaneous carcinogenesis | Q28681056 | ||
| Paradoxical roles of the immune system during cancer development | Q29614305 | ||
| Immunosuppressive networks in the tumour environment and their therapeutic relevance | Q29619244 | ||
| Angiogenesis as a therapeutic target | Q29619525 | ||
| IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity | Q29620119 | ||
| Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells | Q33186709 | ||
| Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense | Q34087551 | ||
| CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets | Q34205998 | ||
| An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy | Q34490538 | ||
| Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer | Q34843832 | ||
| Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments | Q34983123 | ||
| IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway | Q34989745 | ||
| CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages | Q34995099 | ||
| Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis | Q35800371 | ||
| The critical role of type-1 innate and acquired immunity in tumor immunotherapy | Q35911850 | ||
| Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. | Q36229379 | ||
| Gamma delta T cells provide an early source of interferon gamma in tumor immunity | Q36371404 | ||
| The distinct contributions of murine T cell receptor (TCR)gammadelta+ and TCRalphabeta+ T cells to different stages of chemically induced skin cancer | Q36371644 | ||
| Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo | Q36375248 | ||
| Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment | Q36850206 | ||
| Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17 | Q36981811 | ||
| Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment | Q37169987 | ||
| Type 17 CD8+ T cells display enhanced antitumor immunity. | Q37268980 | ||
| IL-6-dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing CD8+ T cells | Q38271046 | ||
| Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway | Q40101993 | ||
| Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment | Q40130406 | ||
| IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis | Q40360012 | ||
| Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals | Q43291519 | ||
| Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses | Q44158655 | ||
| IFN-gamma-dependent type 1 immunity is crucial for immunosurveillance against squamous cell carcinoma in a novel mouse carcinogenesis model. | Q45976146 | ||
| Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. | Q46815296 | ||
| Th1 cell adjuvant therapy combined with tumor vaccination: a novel strategy for promoting CTL responses while avoiding the accumulation of Tregs. | Q53580983 | ||
| Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. | Q53597450 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | angiogenesis | Q539568 |
| P304 | page(s) | 1927-1937 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | European Journal of Immunology | Q5412727 |
| P1476 | title | Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis | |
| P478 | volume | 40 |
| Q41699485 | Activation of iNKT Cells Prevents Salmonella-Enterocolitis and Salmonella-Induced Reactive Arthritis by Downregulating IL-17-Producing γδT Cells |
| Q36059097 | Association of γδ T Cell Compartment Size to Disease Activity and Response to Therapy in SLE. |
| Q92853203 | CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy |
| Q56896815 | CTLA-4 (CD152) enhances the Tc17 differentiation program |
| Q97653023 | Cancer immunotherapy with γδ T cells: many paths ahead of us |
| Q88215974 | Characteristics of γδ T cells in Schistosoma japonicum-infected mouse mesenteric lymph nodes |
| Q36038030 | Characterization and Clinical Implication of Th1/Th2/Th17 Cytokines Produced from Three-Dimensionally Cultured Tumor Tissues Resected from Breast Cancer Patients |
| Q27025504 | Close link between development and function of gamma-delta T cells |
| Q36444174 | Complex role of γδ T-cell-derived cytokines and growth factors in cancer |
| Q42480340 | Constant TCR triggering suggests that the TCR expressed on intestinal intraepithelial γδ T cells is functional in vivo. |
| Q55012882 | Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy. |
| Q26863724 | Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation |
| Q27010199 | Diversity of IL-17-producing T lymphocytes |
| Q84007852 | Driving IL-17⁺ γδ T-cell migration in allergic reactions: a new "inflammatory" role for the "homeostatic" chemokine CCL25 |
| Q37581683 | Effect of IL-17 in the development of colon cancer in mice |
| Q26781175 | Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy |
| Q64057109 | Ex Vivo Expanded Human Vγ9Vδ2 T-Cells Can Suppress Epithelial Ovarian Cancer Cell Growth |
| Q59800422 | Extracellular Vesicle-Mediated Immune Regulation of Tissue Remodeling and Angiogenesis After Myocardial Infarction |
| Q39032098 | Formyl peptide receptor suppresses melanoma development and promotes NK cell migration |
| Q102059535 | Functional and metabolic dichotomy of murine γδ T cell subsets in cancer immunity |
| Q47742552 | Gamma-delta (γδ) T cells: friend or foe in cancer development? |
| Q27026048 | Genetic requirements for the development and differentiation of interleukin-17-producing γδ T cells |
| Q50872714 | High density of IL-17-producing cells is associated with improved prognosis for advanced epithelial ovarian cancer. |
| Q41866168 | Hmgb1-IL-23-IL-17-IL-6-Stat3 axis promotes tumor growth in murine models of melanoma |
| Q47599510 | Human papillomavirus oncoproteins induce a reorganization of epithelial-associated γδ T cells promoting tumor formation |
| Q37714642 | Human γδT-cell subsets and their involvement in tumor immunity. |
| Q37937750 | IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: The significance of modulating such cytokines in treating malignant solid tumors. |
| Q38256438 | IL-17 Expression by macrophages is associated with proliferative inflammatory atrophy lesions in prostate cancer patients |
| Q59808760 | IL-17 in Peritoneal Dialysis-Associated Inflammation and Angiogenesis: Conclusions and Perspectives |
| Q39616587 | IL-17 production by γδ T cells is important for the antitumor effect of Mycobacterium bovis bacillus Calmette-Guérin treatment against bladder cancer |
| Q38040747 | IL-23: one cytokine in control of autoimmunity |
| Q39016421 | IL-7 receptor blockade inhibits IL-17-producing γδ cells and suppresses melanoma development |
| Q40808689 | IL17 producing γδT cells induce angiogenesis and are associated with poor survival in gallbladder cancer patients |
| Q48128395 | Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1. |
| Q38599837 | Immunity and immune modulation in Trypanosoma cruzi infection |
| Q42357971 | Immunosuppressive γδ T cells foster pancreatic carcinogenesis |
| Q55311835 | Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer. |
| Q34570874 | Inhibition of IL-17A in tumor microenvironment augments cytotoxicity of tumor-infiltrating lymphocytes in tumor-bearing mice |
| Q37031654 | Interleukin-17 and type 17 helper T cells in cancer management and research |
| Q38390943 | Interleukin-17 is a favorable prognostic marker for colorectal cancer |
| Q62936781 | Interleukin-Mediated Pendrin Transcriptional Regulation in Airway and Esophageal Epithelia |
| Q36269037 | Langerhans Cells Facilitate UVB-Induced Epidermal Carcinogenesis |
| Q39337563 | Lung-resident γδ T cells and their roles in lung diseases |
| Q38173753 | Molecular Mechanisms of Differentiation of Murine Pro-Inflammatory γδ T Cell Subsets |
| Q34119854 | Murine CD27(-) Vγ6(+) γδ T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages |
| Q98280908 | Myeloid-derived suppressor cell depletion therapy targets IL-17A-expressing mammary carcinomas |
| Q40994227 | Nitric oxide synthase 2 is involved in the pro-tumorigenic potential of γδ17 T cells in melanoma |
| Q33810570 | Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia |
| Q34222410 | Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation |
| Q38998175 | Platelet factor 4 inhibits IL-17/Stat3 pathway via upregulation of SOCS3 expression in melanoma |
| Q57300020 | Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression |
| Q84409413 | Promoting angiogenesis within the tumor microenvironment: the secret life of murine lymphoid IL-17-producing gammadelta T cells |
| Q41475326 | RORγt-expressing cells attenuate cardiac remodeling after myocardial infarction |
| Q36917913 | Redundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis |
| Q38787725 | Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer |
| Q88008277 | Regulatory functions of γδ T cells |
| Q27010451 | Six-of-the-best: unique contributions of γδ T cells to immunology |
| Q35944713 | Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance |
| Q34913808 | Th17 cells in cancer: help or hindrance? |
| Q37706556 | Th1high in tumor microenvironment is an indicator of poor prognosis for patients with NSCLC. |
| Q38362640 | The Jekyll and Hyde story of IL17-Producing γδT Cells |
| Q57816901 | The Role of the Extracellular Matrix and Its Molecular and Cellular Regulators in Cancer Cell Plasticity |
| Q53164307 | The development of IL-17/IFN-γ-double producing CTLs from Tc17 cells is driven by epigenetic suppression of Socs3 gene promoter. |
| Q92628379 | The features of circulating and tumor-infiltrating γδ T cells in melanoma patients display critical perturbations with prognostic impact on clinical outcome |
| Q84975992 | The parallel lives of angiogenesis and immunosuppression: cancer and other tales |
| Q38238738 | The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis. |
| Q38039112 | The split nature of tumor-infiltrating leukocytes: Implications for cancer surveillance and immunotherapy |
| Q38101567 | The tumor microenvironment: a pitch for multiple players. |
| Q93162748 | Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies |
| Q38287973 | Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment. |
| Q55044228 | Tumor-associated neutrophils suppress pro-tumoral IL-17+ γδ T cells through induction of oxidative stress. |
| Q28674494 | U87MG glioma cells overexpressing IL-17 acclerate early-stage growth in vivo and cause a higher level of CD31 mRNA expression in tumor tissues |
| Q38271584 | γδ T Cell-Mediated Immune Responses in Disease and Therapy |
| Q54326921 | γδ T Cells: Unexpected Regulators of Cancer Development and Progression. |
| Q38633738 | γδ T cell-based anticancer immunotherapy: progress and possibilities |
| Q38602555 | γδ T cells in cancer |
| Q90783584 | γδ T cells in cancer: a small population of lymphocytes with big implications |
| Q92826000 | γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer |
| Q38718920 | γδT Cells and Related Diseases |
| Q36473289 | γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. |
| Q50088026 | γδTCR recruits the Syk/PI3K axis to drive proinflammatory differentiation program |
Search more.